×
About 49,588 results

ALLMedicine™ Cardiomyopathy Center

Research & Reviews  17,125 results

Role of CHA2DS2-VASc score in predicting atrial fibrillation recurrence in patients und...
https://doi.org/10.1007/s10840-022-01430-7
Journal of Interventional Cardiac Electrophysiology : an ... Rordorf R, Iacopino S et. al.

Nov 24th, 2022 - Pulmonary vein isolation by cryoablation (PVI-C) is a standard therapy for the treatment of atrial fibrillation (AF). The CHA2DS2-VASc score is a well-established predictor of AF-related stroke. Whether the CHA2DS2-VASc score can also be useful in...

The Predictive Value of Myocardial Native T1 Mapping Radiomics in Dilated Cardiomyopath...
https://doi.org/10.1002/jmri.28527
Journal of Magnetic Resonance Imaging : JMRI; Zhang J, Xu Y et. al.

Nov 24th, 2022 - Investigation of the factors influencing dilated cardiomyopathy (DCM) prognosis is important as it could facilitate risk stratification and guide clinical decision-making. To assess the prognostic value of magnetic resonance imaging (MRI) radiomic...

Risk factors for the development of premature ventricular complex-induced cardiomyopath...
https://doi.org/10.1007/s10840-022-01421-8
Journal of Interventional Cardiac Electrophysiology : an ... de Lavallaz JDF, Mézier J et. al.

Nov 23rd, 2022 - Premature ventricular complexes (PVCs) are a potentially reversible cause of heart failure. However, the characteristics of patients most likely to develop impaired left ventricular function are unclear. Hence, the objective of this study is to sy...

How to interpret cardiac biomarkers in children?
https://doi.org/10.1136/archdischild-2022-324466
Archives of Disease in Childhood. Education and Practice ... McGinn C, Waterfield T et. al.

Nov 23rd, 2022 - Cardiac biomarkers are used as first-line diagnostic tools in suspected myocardial injury and heart failure in adult patients. Their use in paediatric patients has been limited by variability caused by age, gender and the presence of an underlying...

Time has come to sunset the signal-averaged electrocardiogram for evaluation of patient...
https://doi.org/10.1016/j.hrthm.2022.10.022
Heart Rhythm; Wang W, Calkins H

Nov 22nd, 2022 - Time has come to sunset the signal-averaged electrocardiogram for evaluation of patients with suspected arrhythmogenic right ventricular cardiomyopathy.|2022|Wang W,Calkins H,|

see more →

Guidelines  23 results

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic ...
https://doi.org/10.1016/j.echo.2022.03.012
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936
Orphanet Journal of Rare Diseases; Mosbah H, Donadille B et. al.

Apr 21st, 2022 - Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole N...

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary...
https://doi.org/10.1016/j.jtcvs.2021.04.052
The Journal of Thoracic and Cardiovascular Surgery; Bakaeen FG, Gaudino M et. al.

Jul 18th, 2021 - 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.|2021|Bakaeen FG,Gaudino M,Whitman G,Doenst T,Ruel M,|standards,diagnostic im...

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

May 1st, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 3rd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

see more →

Drugs  93 results see all →

Clinicaltrials.gov  1,161 results

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT05374564

Oct 14th, 2022 - The goal of this project is to perform a proof-of-concept study to compare the ability of quantitative parametric cardiac 18F-flutemetamol positron emission tomography (PET) to assess baseline and change in disease burden after six months of thera...

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstru...
https://clinicaltrials.gov/ct2/show/NCT05489705

Oct 14th, 2022 - The purpose of this study is to evaluate the safety of mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) treated in the real-world setting. The registry study also provide a real-world understanding of the curre...

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
https://clinicaltrials.gov/ct2/show/NCT04826185

Oct 13th, 2022 - The purpose of this study is to assess the safety, tolerability, and potential efficacy of IMB-1018972 in patients with non-obstructive HCM.

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001456

Oct 13th, 2022 - Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease consisting of oculocutaneous albinism, a platelet storage pool defect and, in some patients, lysosomal accumulation of ceroid lipofuscin. Other manifestations include pulmonary ...

Renal Denervation in Hypertrophic Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT05577208

Oct 13th, 2022 - According to current literature, approximately two-thirds of patients with HCM have persistent symptoms despite conventional treatment. For this reason, novel nonpharmacological therapies such as cardiac resynchronization, endocardial catheter abl...

see more →

News  1,354 results

Test for 'Concealed Cardiomyopathy' After Sudden Unexplained Death
https://www.medscape.com/viewarticle/984542

Nov 23rd, 2022 - Genetic testing after sudden unexplained death in a young person with inconclusive autopsy results needs to be expanded to include gene variants for cardiomyopathy, a new study shows. Researchers found that among 91 people who died suddenly and in...

Illegal Diet Supplements for CVD; Lung Disease in OAC Users; Myocarditis Mechanism
https://www.medpagetoday.com/cardiology/prevention/101876

Nov 22nd, 2022 - FDA sent warnings to seven companies selling dietary supplements with unlawful claims of treating or preventing cardiovascular disease. A study from Taiwan showed that there was an increased risk of interstitial lung disease in people using oral a...

Did the ISCHEMIA Trial Change the Path to Cath in Stable Coronary Artery Disease?
https://www.medscape.com/viewarticle/983644

Nov 21st, 2022 - This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi. I'm Dr Michelle O'Donoghue reporting for Medscape. Joining me today are two interventional cardiologists with whom I've had the pleasure of speaking with in the past...

Early Cardiac Amyloidosis Still Bad News Without Treatment
https://www.medpagetoday.com/cardiology/prevention/101789

Nov 16th, 2022 - For asymptomatic patients diagnosed with early-stage transthyretin amyloid cardiomyopathy (ATTR-CM), it can take just a few years to progress to clinical heart failure or other cardiovascular complications, according to a longitudinal cohort study...

Morning vs Midday Exercise; LVADs and Cancer; Reperfusion Injury After Thrombectomy
https://www.medpagetoday.com/cardiology/prevention/101759

Nov 15th, 2022 - Is diabetes slipping in importance as a cardiovascular risk factor? (JAMA) Morning exercisers in the U.K. Biobank tended to have lower cardiovascular disease risk than those saving their physical activity for midday. (European Journal of Preventiv...

see more →

Patient Education  79 results see all →